Denali Therapeutics Inc.

Rachunek Zysków i Strat


index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
Rok finansowy 2016 2016 2016 2016 2017 2017 2017 2017 2018 2018 2018 2018 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024 2025
Kwartał Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1
Data 2016-03-31 2016-06-30 2016-09-30 2016-12-31 2017-03-31 2017-06-30 2017-09-30 2017-12-31 2018-03-31 2018-06-30 2018-09-30 2018-12-31 2019-03-31 2019-06-30 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31
Przychód (mln) 0 0 0 0 0 0 0 145 1 2 1 126 4 4 14 5 4 6 9 317 8 23 5 13 42 52 4 10 35 294 1 -305 0 0 0 0 0
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% inf% inf% inf% -13.42% 556.0% 154.7% 1038.4% -96.28% -14.29% 39.3% -30.95% 6681.1% 119.8% 292.3% -43.73% -96.05% 431.9% 128.8% -32.66% -17.83% -16.61% 460.4% -64.40% -3066.48% -100.00% -100.00% -100.00% -100.00% 0.0%
Marża brutto 0.0% 0.0% 0.0% 0.0% -inf% -inf% -inf% 87.3% -3147.89% -3063.47% -2437.32% 68.2% -789.49% -1136.22% -286.24% -1003.40% -1315.54% -809.05% -471.74% 82.7% -659.90% -186.46% -1254.00% 89.5% 96.9% 97.7% 64.1% 68.6% 73.9% 99.5% -74.98% 100.7% -inf% -inf% 0.0% 0.0% 0.0%
Koszty i Wydatki (mln) 18 18 31 20 22 23 22 24 26 59 39 51 47 67 64 62 64 67 70 73 79 85 91 90 109 114 111 116 156 124 115 133 132 117 123 130 146
EBIT (mln) -18 -18 -26 -20 -22 -23 -22 -24 -26 -57 -38 75 -43 -63 -50 -58 -60 -61 -60 244 -71 -62 -86 -77 -66 -61 -107 -105 -121 170 -114 -133 -132 -117 -123 -130 -146
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 18.4% 22.9% -13.05% 18.5% 18.4% 154.3% 70.3% 417.4% 65.1% 9.4% 32.1% -177.30% 41.1% -2.37% 19.9% 522.6% 18.8% 0.9% 42.4% -131.60% -6.63% -0.65% 25.6% 36.6% 81.7% 377.6% 5.9% 25.8% 9.5% -168.39% 8.3% -2.06% 10.1%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -16.22% -4016.85% -3481.92% -3176.90% 59.5% -1010.89% -1495.43% -368.68% -1236.26% -1663.90% -1048.01% -640.01% 77.0% -898.90% -269.48% -1619.55% -616.28% -157.80% -117.03% -3020.12% -1024.45% -343.80% 58.0% -8981.45% 43.5% 0.0% 0.0% 0.0% nan nan
Przychody fiansowe (mln) 0 0 0 0 0 0 0 1 2 3 3 3 4 4 4 4 3 3 2 2 1 1 1 1 1 3 4 7 11 13 14 13 16 18 16 15 13
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15 0 0 0 0 0 0 0 0 1 3 4 7 0 0 0 21 0 0 0 0 0
Amortyzacja (mln) 0 0 0 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 1 1 1 3 9 1 2 2 2 2 0 3 3
EBITDA (mln) -18 -18 -25 -19 -21 -22 -22 -23 -25 -56 -36 77 -40 -61 -48 -56 -58 -59 -58 246 -69 -60 -83 -77 -64 -59 -105 -101 -111 170 -112 -130 -130 -115 -123 -127 -142
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -16.22% -3883.62% -3369.36% -2982.18% 59.5% -953.75% -1456.28% -354.79% -1236.26% -1605.38% -1011.32% -617.06% 77.0% -898.90% -259.88% -1578.16% -616.28% -152.87% -113.08% -2959.96% -984.66% -343.80% 58.0% -8806.47% 42.7% 0.0% 0.0% 0.0% nan nan
NOPLAT (mln) -18 -18 -31 -19 -21 -22 -22 -23 -24 -55 -35 78 -39 -59 -46 -54 -57 -59 -58 246 -70 -61 -85 -76 -65 -59 -103 -99 -110 183 -99 -119 -102 -99 -107 -115 -133
Podatek (mln) 0 0 0 0 0 0 0 -1 0 0 0 -2 0 -0 -0 0 -0 0 0 1 -2 1 1 -1 -1 0 2 -0 -10 -2 2 0 2 0 0 0 0
Zysk Netto (mln) -18 -18 -31 -19 -21 -22 -22 -23 -24 -55 -35 78 -39 -58 -46 -54 -57 -59 -58 245 -70 -61 -85 -75 -64 -59 -103 -99 -110 183 -99 -119 -102 -99 -107 -115 -133
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 16.2% 20.7% -28.64% 18.3% 11.1% 147.2% 61.9% 438.8% 64.7% 6.6% 30.8% -169.68% 45.6% 0.7% 25.9% 553.3% 23.4% 3.3% 45.3% -130.73% -8.71% -3.13% 22.1% 31.1% 71.7% 411.9% -3.82% 21.1% -7.27% -154.00% 7.9% -3.95% 30.6%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -15.77% -3693.92% -3320.63% -2959.92% 61.7% -927.28% -1389.97% -340.05% -1156.36% -1575.00% -1004.93% -619.91% 77.3% -884.02% -264.58% -1600.53% -601.41% -151.73% -112.03% -2902.47% -959.62% -312.40% 62.3% -7841.59% 39.2% 0.0% 0.0% 0.0% nan nan
EPS -3.37 -3.37 -4.51 -2.15 -2.36 -0.32 -0.27 -0.74 -0.26 -0.59 -0.38 0.82 -0.41 -0.61 -0.48 -0.57 -0.55 -0.56 -0.54 2.04 -0.58 -0.5 -0.69 -0.62 -0.52 -0.48 -0.84 -0.74 -0.8 1.34 -0.72 -0.86 -0.68 -0.59 -0.63 -0.67 -0.78
EPS (rozwodnione) -3.37 -3.37 -4.51 -2.15 -2.36 -0.32 -0.27 -0.74 -0.26 -0.59 -0.38 0.79 -0.41 -0.61 -0.48 -0.56 -0.55 -0.56 -0.54 1.91 -0.58 -0.49 -0.69 -0.62 -0.52 -0.48 -0.84 -0.74 -0.8 1.3 -0.72 -0.86 -0.68 -0.59 -0.63 -0.67 -0.78
Ilośc akcji (mln) 5 5 7 9 9 68 82 31 90 93 94 94 95 95 96 96 102 106 107 120 121 121 122 122 123 122 123 133 137 137 138 138 149 169 169 170 171
Ważona ilośc akcji (mln) 5 5 7 9 9 68 82 31 90 93 94 98 95 95 96 96 102 106 107 128 121 123 122 122 123 123 123 133 137 141 138 138 149 169 169 170 171
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD